We are looking for visionary investors and partners to help us build the microbiome solutions of the future.
partners & investors.
The microbiome field has seen a growing attention, not only from science and investors but also the general public in recent years.
Imbalances in the microbiome in the human gut have been linked to diseases like Irritable Bowel Syndrome (IBS). Estimates suggest that more than 10% of the population in the developed world is affected by IBS and on average 1 day a week of work is missed due to IBS. The microbiome field is large and growing. It pertains not only to the human gut and skin, but also agriculture and farming industries. The growth and increase in interest in the microbiome field has driven an increase in demand for rapid and precise measurement tools.
Cutting edge testing methods are and will be a key driver for clinical studies and evidence-based treatment methods in the microbiome industry. Accurate measurement tools will demonstrate the effect of probiotics on patients, identify sub populations benefiting the most from treatment, provide evidence required to claim therapeutic effect, allow for targeted product development and lifestyle adjustment suggestions.
REM Analytics provides the critical measurement tools that will lead to a new generation of probiotics, based on a lineage tracing technology.
We help the microbiome industry do more, faster and better.